Obesity and peripheral artery disease: Current evidence and controversies
Abstract Purpose of Review Obesity is a significant public health problem and a major risk
factor for the development and progression of atherosclerosis and its cardiovascular …
factor for the development and progression of atherosclerosis and its cardiovascular …
Dietary risk factors and eating behaviors in peripheral arterial disease (PAD)
AL Cecchini, F Biscetti, MM Rando, E Nardella… - International Journal of …, 2022 - mdpi.com
Dietary risk factors play a fundamental role in the prevention and progression of
atherosclerosis and PAD (Peripheral Arterial Disease). The impact of nutrition, however …
atherosclerosis and PAD (Peripheral Arterial Disease). The impact of nutrition, however …
Sex differences in risk factors for incident peripheral artery disease hospitalisation or death: Cohort study of UK Biobank participants
Background Women with peripheral artery disease (PAD) often have atypical symptoms, late
hospital presentations, and worse prognosis. Risk factor identification and management are …
hospital presentations, and worse prognosis. Risk factor identification and management are …
Mortality risk assessment in peripheral arterial disease—the burden of cardiovascular risk factors over the years: a single center's experience
V Aursulesei Onofrei, A Ceasovschih, DTM Marcu… - Diagnostics, 2022 - mdpi.com
Atherosclerosis is the basis of the cardiovascular continuum in peripheral artery disease
(PAD) patients. Limiting functional decline and increasing quality of life are the main …
(PAD) patients. Limiting functional decline and increasing quality of life are the main …
Genetic evidence for a causal relationship between type 2 diabetes and peripheral artery disease in both Europeans and East Asians
Background Observational studies have revealed that type 2 diabetes (T2D) is associated
with an increased risk of peripheral artery disease (PAD). However, whether the two …
with an increased risk of peripheral artery disease (PAD). However, whether the two …
Antihypertensive medication use trajectories after bariatric surgery: a matched cohort study
BACKGROUND: Metabolic and bariatric surgery (MBS) is the most effective and durable
treatment for obesity. We aimed to compare the trajectories of antihypertensive medication …
treatment for obesity. We aimed to compare the trajectories of antihypertensive medication …
Emerging Medical Therapies for the Treatment of Obesity in Women with Cardiovascular Diseases
L Behrooz, CG Lenneman, NM Hamburg - Current Cardiology Reports, 2023 - Springer
Abstract Purpose of Review In this review, the impact of obesity on cardiovascular disease in
women and emerging anti-obesity pharmacologic treatments are discussed. Recent …
women and emerging anti-obesity pharmacologic treatments are discussed. Recent …
Peripheral arterial disease and intermittent claudication in coronary heart disease patients
Ž Reiner, J De Sutter, L Ryden, E Mirrakhimov… - International Journal of …, 2021 - Elsevier
Background and aim Peripheral artery disease (PAD) is associated with an increased risk of
fatal and non-fatal coronary heart disease (CHD). The aims of the this study were 1) to …
fatal and non-fatal coronary heart disease (CHD). The aims of the this study were 1) to …
Association of Undernutrition With Mortality and Amputation Outcomes in Chronic Limb Threatening Ischaemia: A Systematic Review
LE Scierka, J Cleman, AE Brice, AA Grimshaw… - European Journal of …, 2024 - Elsevier
Objective Nutritional status plays a complex role in the pathophysiology and outcomes of
chronic limb threatening ischaemia (CLTI). Undernutrition may be a modifiable risk factor …
chronic limb threatening ischaemia (CLTI). Undernutrition may be a modifiable risk factor …
Diet-induced obesity augments ischemic myopathy and functional decline in a murine model of peripheral artery disease
E Fletcher, D Miserlis, K Sorokolet, D Wilburn… - Translational …, 2023 - Elsevier
Peripheral artery disease (PAD) causes an ischemic myopathy contributing to patient
disability and mortality. Most preclinical models to date use young, healthy rodents with …
disability and mortality. Most preclinical models to date use young, healthy rodents with …